Startups
Corindus, A Siemens Healthineers Company, is a global technology leader in robotic-assisted vascular interventions. The Company’s CorPath® platform is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. CorPath GRX is the second generation robotic-assisted technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. We are focused on developing innovative robotic solutions to revolutionize treatment of emergent conditions by providing specialized and timely medical care to patients around the world.
For additional information, visit www.corindus.com, and follow @CorindusInc.
For additional information, visit www.corindus.com, and follow @CorindusInc.
Overview
Location
United States, Massachusetts, Waltham
Employees
51-200
Phone
+1 508-653-3335
Total raised
$45M
Founded date
2002
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 16, 2021 | Advanced Dermatology, P.C. adds ten new Nevisense installations to its extensive practice network. | Stockholm, Sweden and New York, US, - December 16, 2021 - SciBase Holding AB ("SciBase") [STO:SCIB], a leader of augmented intelligence-based solutions for skin disorders, announced today that it has received an order of ten addit... |
| Dec 16, 2021 | Advanced Dermatology, P.C. adds ten new Nevisense installations to its extensive practice network. | Advanced Dermatology, P.C. adds ten new Nevisense installations to its extensive practice network. Thu, Dec 16, 2021 08:00 CET Stockholm, Sweden and New York, US, - December 16, 2021 - SciBase Holding AB ("SciBase") [STO:SCIB], a ... |
| Sep 1, 2021 | Безмозглые хирурги: прошлое, настоящее и будущее медицинских роботов | Считается, что роботы-хирурги — технология будущего, но они принципиально не менялись вот уже 20 лет. Некоторые врачи считают роботов-хирургов ненужной тратой денег, в то время как другие — в восторге от открывающихся возможностей. Большинс... |
| Jan 13, 2020 | 2019 was record year for life sciences M&A and plenty of firepower left in 2020 | Companies also could feel a need to invest more in data-driven and digital technologies, the report said. If they decide to pull the trigger, buyers have plenty of capital, according to the report. Life-sciences companies are sitting on mor... |
| Feb 28, 2017 | Corindus Vascular Robotics Closes $45M Private Placement | WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a leading developer of precision vascular robotics, announced today that it has entered into a Securities Purchase Agreement pursuant to which it will issue... |
| Sep 15, 2014 | Corindus raises $26.6M for vascular robot | Massachusetts-based Corindus Vascular Robotics has big plans for its newly secured $26.6 million, raised in a private placement funding round. Corindus sold nearly 10.7 million shares at $2.50 apiece through a Securities Purchase Agreement,... |
| Feb 27, 2013 | The Rise of Robotics in Med Tech | Robots represent a vision of the future, a vision that inspires two parts amazement and one part fear of being replaced by superior machines. In manufacturing, robots have been deployed since the 1960’s to exceed human precision and product... |
| 2019 was record year for life sciences M&A and plenty of firepower left in 2020 | Big pharma drove M&A value in the life-sciences field to a record high in 2019. That record is likely to remain standing, at least for 2020, but companies still face pressure to strike deals, according to an annual report on M&A by ... | |
| The Rise of Robotics in Med Tech | Robots represent a vision of the future, a vision that inspires two parts amazement and one part fear of being replaced by superior machines. In manufacturing, robots have been deployed since the 1960’s to exceed human precision and product... |
Reviews 0
FAQ about Corindus Vascular Robotics
When was Corindus Vascular Robotics founded?
Corindus Vascular Robotics was founded in 2002.
How much funding has Corindus Vascular Robotics raised?
Corindus Vascular Robotics has raised $45M in total across 1 funding round.
What has the press written about Corindus Vascular Robotics?
Parsers VC has collected 10 articles mentioning Corindus Vascular Robotics, among them “Advanced Dermatology, P.C. adds ten new Nevisense installations to its extensive practice network.” (Dec 16, 2021) and “Advanced Dermatology, P.C. adds ten new Nevisense installations to its extensive practice network.” (Dec 16, 2021).
Is Corindus Vascular Robotics still active?
Yes, Corindus Vascular Robotics is active; its latest activity on Parsers VC dates from Jun 12, 2026.